679 related articles for article (PubMed ID: 21769843)
1. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival.
Humbert M; Yaici A; de Groote P; Montani D; Sitbon O; Launay D; Gressin V; Guillevin L; Clerson P; Simonneau G; Hachulla E
Arthritis Rheum; 2011 Nov; 63(11):3522-30. PubMed ID: 21769843
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand.
Foocharoen C; Nanagara R; Kiatchoosakun S; Suwannaroj S; Mahakkanukrauh A
Int J Rheum Dis; 2011 Aug; 14(3):282-9. PubMed ID: 21816025
[TBL] [Abstract][Full Text] [Related]
3. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M;
Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881
[TBL] [Abstract][Full Text] [Related]
4. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
Le Pavec J; Girgis RE; Lechtzin N; Mathai SC; Launay D; Hummers LK; Zaiman A; Sitbon O; Simonneau G; Humbert M; Hassoun PM
Arthritis Rheum; 2011 Aug; 63(8):2456-64. PubMed ID: 21538327
[TBL] [Abstract][Full Text] [Related]
5. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
[TBL] [Abstract][Full Text] [Related]
6. Survival in childhood pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management.
Barst RJ; McGoon MD; Elliott CG; Foreman AJ; Miller DP; Ivy DD
Circulation; 2012 Jan; 125(1):113-22. PubMed ID: 22086881
[TBL] [Abstract][Full Text] [Related]
7. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.
Nihtyanova SI; Tang EC; Coghlan JG; Wells AU; Black CM; Denton CP
QJM; 2010 Feb; 103(2):109-15. PubMed ID: 19966313
[TBL] [Abstract][Full Text] [Related]
8. The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH.
Clements PJ; Tan M; McLaughlin VV; Oudiz RJ; Tapson VF; Channick RN; Rubin LJ; Langer A;
Ann Rheum Dis; 2012 Feb; 71(2):249-52. PubMed ID: 21998119
[TBL] [Abstract][Full Text] [Related]
9. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
[TBL] [Abstract][Full Text] [Related]
10. Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease.
Johnson SR; Granton JT; Tomlinson GA; Grosbein HA; Le T; Lee P; Seary ME; Hawker GA; Feldman BM
J Rheumatol; 2012 Feb; 39(2):276-85. PubMed ID: 22247353
[TBL] [Abstract][Full Text] [Related]
11. Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.
Mathai SC; Hummers LK; Champion HC; Wigley FM; Zaiman A; Hassoun PM; Girgis RE
Arthritis Rheum; 2009 Feb; 60(2):569-77. PubMed ID: 19180517
[TBL] [Abstract][Full Text] [Related]
12. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
[TBL] [Abstract][Full Text] [Related]
13. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
14. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis.
Hofstee HM; Vonk Noordegraaf A; Voskuyl AE; Dijkmans BA; Postmus PE; Smulders YM; Serné EH
Ann Rheum Dis; 2009 Feb; 68(2):191-5. PubMed ID: 18375538
[TBL] [Abstract][Full Text] [Related]
15. Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry.
Chung L; Domsic RT; Lingala B; Alkassab F; Bolster M; Csuka ME; Derk C; Fischer A; Frech T; Furst DE; Gomberg-Maitland M; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TA; Molitor JA; Preston IR; Schiopu E; Shapiro L; Silver R; Simms R; Varga J; Gordon JK; Steen VD
Arthritis Care Res (Hoboken); 2014 Mar; 66(3):489-95. PubMed ID: 23983198
[TBL] [Abstract][Full Text] [Related]
16. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.
Hachulla E; Gressin V; Guillevin L; Carpentier P; Diot E; Sibilia J; Kahan A; Cabane J; Francès C; Launay D; Mouthon L; Allanore Y; Tiev KP; Clerson P; de Groote P; Humbert M
Arthritis Rheum; 2005 Dec; 52(12):3792-800. PubMed ID: 16320330
[TBL] [Abstract][Full Text] [Related]
17. Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study.
Pasarikovski CR; Granton JT; Roos AM; Sadeghi S; Kron AT; Thenganatt J; Moric J; Chau C; Johnson SR
Arthritis Res Ther; 2016 Jan; 18():30. PubMed ID: 26819137
[TBL] [Abstract][Full Text] [Related]
18. Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension.
Valerio CJ; Schreiber BE; Handler CE; Denton CP; Coghlan JG
Arthritis Rheum; 2013 Apr; 65(4):1074-84. PubMed ID: 23280155
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS).
Kolstad KD; Li S; Steen V; Chung L;
Chest; 2018 Oct; 154(4):862-871. PubMed ID: 29777655
[TBL] [Abstract][Full Text] [Related]
20. Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult.
Hesselstrand R; Wildt M; Ekmehag B; Wuttge DM; Scheja A
Scand J Rheumatol; 2011 Mar; 40(2):127-32. PubMed ID: 20858146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]